Facebook
Twitter
LinkedIn
ForwardMCI Radiation Oncology Grand Rounds – Proton Therapy for Bone and Soft Tissue Sarcomas
Proton therapy has successfully been used to treat a variety of sarcomas with a low incidence of side effects. This means that higher doses of radiation can be used to treat bone and soft tissue sarcomas, and that these higher doses will cause minimal damage to other healthy tissues.
During this conference participants will understand optimal integration of radiation therapy with surgery and systemic therapy for bone and soft tissue sarcoma.
Target Audience
Radiation Oncologists, Medical Oncologists, Oncology Surgeons and Radiologists
NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.
Learning Objectives
- Implement appropriate optimal integration of radiation therapy with surgery and systemic therapy for bone and soft tissue sarcomas.
- Identify potential non-surgical treatment options for patients with axial sarcomas where results for which surgery has been sub-optimal.
Thomas F. DeLaney, M.D.
Andres Soriano Professor of Radiation Oncology, Harvard Medical School
Radiation Oncologist, Department of Radiation Oncology
Associate Medical Director- Francis H. Burr Proton Therapy Center
Co-Director, Center for Sarcoma and Connective Tissue Oncology
Massachusetts General Hospital
Boston M.A.
Thomas F. DeLaney, M.D., indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Michael D. Chuong, M.D.
Radiation Oncologist
Baptist Health Quality Network
Baptist and South Miami Hospitals
Miami, Florida
Dr. Chuong has indicated he has received grant/research support from AstraZeneca and ViewRay. He is on the speakers' bureau for Viewray, Accuray and Sirtex and his discussion will not include mention of investigational or off-label usage.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-621028, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit hour for Nurses and Nurse Practitioners. Baptist Health South Florida CE Broker Provider #50-182.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Respiratory Therapy
NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.